Kite Pharma, a Gilead company, is significantly expanding its ability to manufacture a variety of CAR-T therapies, including Yescarta, for both clinical and commercial use with a new biologics facility in Urbana, MD
Transforming Feed Safety: From Compliance to Proactive Risk Management GMP+ International Managing Director Martine Boon brings extensive experience in feed safety, sustainability, and agrifood transition to the global feed industry
There were no significant differences between the exposed and unexposed obesity groups for gestational diabetes, use of insulin, or use of metformin
Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation
The compound continues to predictably generate incredibly strong interest within the global scientific community due to its highly novel mechanism of action and remarkably broad metabolic research potential